Connectez-vous pour accéder aux recommandations de stratégie gagnante.
Se connecterPassez à un plan supérieur pour voir quelles entreprises sont susceptibles de soumissionner pour cet appel d'offres, basé sur les données historiques.
Se connecter5 exigences dans 5 catégories
Inscrivez-vous pour consulter les exigences et l'analyse complètes
9 documents disponibles avec des résumés IA
This document contains the tender conditions for the procurement of the medication Rufinamidas by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.
This document contains the special conditions for the purchase and sale agreement of the medicinal product Rufinamid.
This document is the European Single Procurement Document (ESPD) Annex 3, used for the procurement of the medication Rufinamid by the Lithuanian University of Health Sciences Hospital Kaunas Clinics.
This document contains a tender notice for the procurement of Rufinamidas medication by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.
This document contains the general terms and conditions for a purchase and sale agreement for goods, defining key terms and outlining the interpretation and hierarchy of contract documents, specifically in the context of procuring the medication Rufinamidas.
This document contains the technical specification for the medication Rufinamidum 40mg/ml 460ml oral suspension, outlining requirements for registration, labeling, and shelf life.
This document is a product list (Prekių žiniaraštis) for Rufinamidum 40mg/ml oral suspension, specifying item number, code, name, unit of measure, quantity, and price details.
This document outlines the structure of a tender for Rufinamidas medication, specifying an open procedure with the lowest price as the evaluation type for round 1.
This document contains a request for information regarding participation in criminal organizations as an exclusion criterion for the procurement of Rufinamid medication.
Inscrivez-vous pour consulter les résumés et l'analyse des documents
This tender for Rufinamidas medication is generally well-structured with clear documentation, but lacks specific evaluation criteria and detailed requirements for eligibility and capabilities. The estimated value is undisclosed, impacting full transparency.
The tender adheres to EU procurement directives and provides necessary documents like contract drafts and technical specifications. The CPV code is appropriate. However, the absence of a 'reveal date' for bids and the lack of specified evaluation criteria are minor procedural gaps.
The description of the procured item is clear, and the attached documents provide substantial detail on the medication and contract terms. However, the absence of explicit requirements for exclusion, eligibility, technical, and financial capabilities leaves some aspects open to interpretation.
Most essential information is present, including the organization, reference number, contract duration, and CPV code. A significant number of documents are provided. However, the estimated value is not disclosed, and specific requirements for various aspects of the tender are missing.
The tender is open and uses e-procurement, promoting accessibility. The disclosure of contract drafts and technical specifications is good. The lack of disclosed estimated value and the absence of detailed, objective evaluation criteria could be perceived as minor limitations to full transparency.
The tender is active and uses e-procurement, which is positive. However, the 'Issues' section notes 'No e-submission', which contradicts the 'E-Procurement' characteristic and needs clarification. The contract start date is not specified, and financing information is absent.
Key fields such as title, reference, organization, and CPV code are populated. The dates provided are logical, and there are no reported disputes or suspensions. The contract duration is clearly stated.
The tender is marked as 'EU Funded', which often implies adherence to certain standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information.
Inscrivez-vous pour consulter les exigences et l'analyse complètes
Aucune carte de crédit requise • Configuration en 2 minutes
Nos experts en marchés publics préparent tout. Solution éprouvée — vous relisez, validez et soumettez.
Bonjour ! Je suis votre assistant IA pour cet appel d'offres. Je peux vous aider à comprendre les exigences, les délais, les critères d'admissibilité et vous fournir des informations stratégiques.
Aucune carte de crédit requise